Sunday, April 17, 2005
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience
The Journal : Current Issue: "Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study"
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment